UAE (United Arab Emirates) issues new blood products law:
This article was originally published in Clinica
The UAE Ministry of health last week introduced new guidelines aimed at restricting the import of blood derivatives and other biological substances. In future, such imports will have to be clearly labelled that their country of origin is free from infectious or epidemic diseases. If a company has not had the products screened in the country of origin, it must obtain a safety certificate from a laboratory approved by a member of the Gulf Co-operation Council (GCC).